Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cambridge Biologics, LLC is a biotechnology company based in Brookline, Massachusetts, that provides high-quality biological reagents and specialized research services to the global life sciences community. The company offers an extensive catalog of over 10,000 products, including monoclonal and polyclonal antibodies and recombinant proteins, with a strong focus on virology, oncology, immunology, and neurology. Cambridge Biologics is particularly recognized for its contributions to HIV-1 and RSV research, supplying critical reagents used in vaccine development and therapeutic studies. In addition to its reagent business, the company provides CRO services such as antibody humanization and isolation, and is actively developing its own pipeline of preclinical drug candidates using proprietary bispecific and multi-specific antibody platforms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cambridge Biologics.